EINDHOVEN, the Netherlands — January 17, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces the start of the HemON NL clinical feasibility study at Sint Maartenskliniek in Nijmegen, the Netherlands.
